NEW YORK (GenomeWeb News) – Ariosa Diagnostics today announced a partnership with Laboratory Corporation of America and Integrated Genetics to make its T21 test available in the US and Canada.

Integrated Genetics is a member of LabCorp's Specialty Testing Group. Financial and other terms of the deal were not disclosed.

Ariosa's test, called the Harmony Prenatal Test, will be offered through LabCorp and its more-than-1,000 patient service centers. The test is being made available at select locations and will be broadly launched next month, Ariosa said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.